American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Friday's optimism in Wall Street brought cheer to the Nifty and Sensex in the Monday morning trade, as bulls took over the ...

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...

Governments and global health groups are working to try to fill the most urgent gaps in the fight against diseases such as ...

The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Domestic stock indices saw minor gains on Monday, buoyed by receding fears of a US government shutdown and anticipation of the US Federal Reserve's upcoming policy review. The Nifty closed just above ...

Ahead of the Fourth High-Level Meeting of the UN General Assembly on the prevention and control of NCDs and mental health this September, the global trade association representing the pharmaceutical ...

Benchmark indices end mixed as BSE Sensex closes slightly lower, NSE Nifty edges up; selective buying boosts recovery amid ...